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Background
The current article is a systematic registration and
meta-analysis of the available clinical trials concerning
the usefulness of aripiprazole in the treatment of the
psychotic symptoms in bipolar disorder.
Materials and methods
A systematic MEDLINE and repositories search con-
cerning clinical trials for aripiprazole in bipolar disorder.
Results
The meta-analysis of 4 RCTs on acute mania suggests
that the effect size of aripiprazole vs. placebo was equal
to 0.14 but a more reliable and accurate estimation is
0.18 for the total PANSS score. The effect was higher
for the PANSS positive subscale (0.28), PANSS hostility
subscale (0.24) and PANSS cognitive subscale (0.20),
and lower for the PANSS negative (0.12). No data on
the depressive phase of bipolar illness exist, while there
a r es o m ed a t ai nf a v o u ro fa r i piprazole concerning the
maintenance phase, where at week 26 all except the
total PANSS score showed a significant superiority of
aripiprazole over placebo (d = 0.28 for positive, d = 0.38
for the cognitive and d = 0.71 for the hostility subscales)
and at week 100 the results were similar (d = 0.42, 0.63
and 0.48 respectively).
Conclusions
T h ed a t aa n a l y s e df o rt h ec u r r e n ts t u d ys u p p o r tt h e
usefulness of aripiprazole against psychotic symptoms
during the acute manic and maintenance phases of
bipolar illness.
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